Perugia, Italy

Paolo Puccetti

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paolo Puccetti

Introduction

Paolo Puccetti is a notable inventor based in Perugia, Italy. He has made significant contributions to the field of medical research, particularly in the treatment of immune disorders and diabetes. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.

Latest Patents

One of his latest patents is focused on the use of indole-3-aldehyde for treating dysreactive immune disorders. This patent proposes the therapeutic use of bacteria, specifically lactobacilli, which produce indole-3-aldehyde, as a means of prevention and treatment for immune dysreactive disorders characterized by hyper-inflammatory or autoimmune components. Another significant patent involves a microencapsulation process of Sertoli cells, which are microencapsulated into hydrogel-based microcapsules. This invention aims to prevent and treat Type 1 diabetes mellitus (T1DM) and includes a process for producing these microcapsules, preferably shaped as microspheres.

Career Highlights

Throughout his career, Paolo Puccetti has worked with esteemed institutions such as the Università Degli Studi Di Perugia and GH Care Inc. His research and innovations have contributed to the understanding and treatment of complex medical conditions.

Collaborations

Paolo has collaborated with notable colleagues, including Luigina Romani and Teresa Zelante. Their combined efforts have furthered research in their respective fields and enhanced the impact of their work.

Conclusion

Paolo Puccetti's innovative patents and collaborations highlight his dedication to improving medical treatments. His contributions are paving the way for advancements in healthcare, particularly in the management of immune disorders and diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…